124 related articles for article (PubMed ID: 32798773)
1. The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression - Lessons from primary aldosteronism.
Murck H; Schlageter L; Schneider A; Adolf C; Heinrich D; Quinkler M; Beuschlein F; Reincke M; Künzel H
J Psychiatr Res; 2020 Nov; 130():82-88. PubMed ID: 32798773
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxiety.
Murck H; Adolf C; Schneider A; Schlageter L; Heinrich D; Ritzel K; Sturm L; Quinkler M; Beuschlein F; Reincke M; Künzel H
J Psychiatr Res; 2021 May; 137():376-382. PubMed ID: 33761426
[TBL] [Abstract][Full Text] [Related]
3. Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression.
Engler L; Heinrich DA; Adolf C; Riester A; Franke A; Pawlowski M; Beuschlein F; Reincke M; Steiger A; Künzel H
J Psychiatr Res; 2019 May; 112():52-60. PubMed ID: 30852427
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study.
Apostolopoulou K; Künzel HE; Gerum S; Merkle K; Schulz S; Fischer E; Pallauf A; Brand V; Bidlingmaier M; Endres S; Beuschlein F; Reincke M
World J Biol Psychiatry; 2014 Jan; 15(1):26-35. PubMed ID: 22568586
[TBL] [Abstract][Full Text] [Related]
5. The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism.
Vecchiola A; Fuentes CA; Barros ER; Martínez-Aguayo A; García H; Allende F; Solari S; Olmos R; Carvajal C; Tapia-Castillo A; Campino C; Kalergis AM; Baudrand R; Fardella CE
Am J Hypertens; 2019 Apr; 32(5):468-475. PubMed ID: 30753255
[TBL] [Abstract][Full Text] [Related]
6. Sleep disturbances in primary aldosteronism are associated to depressive symptoms - Could specific mineralocorticoidreceptors be a common pathway?
Adolf C; Murck H; Sarkis AL; Schneider H; Fischer I; Steiger A; Braun LT; Reincke M; Künzel H
J Psychiatr Res; 2024 Apr; 172():66-70. PubMed ID: 38367319
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
8. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
[TBL] [Abstract][Full Text] [Related]
9. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
10. Target-based biomarker selection - Mineralocorticoid receptor-related biomarkers and treatment outcome in major depression.
Büttner M; Jezova D; Greene B; Konrad C; Kircher T; Murck H
J Psychiatr Res; 2015; 66-67():24-37. PubMed ID: 25959615
[TBL] [Abstract][Full Text] [Related]
11. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
[TBL] [Abstract][Full Text] [Related]
12. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.
Ohno Y; Sone M; Inagaki N; Kawashima A; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Ichijo T; Katabami T; Wada N; Sakamoto R; Ogawa Y; Yoshimoto T; Yamada T; Kawashima J; Matsuda Y; Kobayashi H; Kamemura K; Yamamoto K; Otsuki M; Okamura S; Izawa S; Okamoto R; Tamura K; Tanabe A; Naruse M;
Hypertension; 2020 Jun; 75(6):1475-1482. PubMed ID: 32248705
[TBL] [Abstract][Full Text] [Related]
13. Tp-e interval, Tp-e/QT and Tp-e/QTc ratio in hypertensive patients with primary aldosteronism.
Demirtas D; Sumbul HE; Bulut A; Demirtas AO; Gulumsek E; Koca H; Icen YK; Koc M
Clin Exp Hypertens; 2020; 42(1):93-98. PubMed ID: 31204516
[No Abstract] [Full Text] [Related]
14. PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION.
Galati SJ; Cheesman KC; Springer-Miller R; Hopkins SM; Krakoff L; Bagiella E; Zhuk RA; Ying TK; Amer C; Boyajian MK; Inabnet WB; Levine AC
Endocr Pract; 2016 Nov; 22(11):1296-1302. PubMed ID: 27893293
[TBL] [Abstract][Full Text] [Related]
15. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
[TBL] [Abstract][Full Text] [Related]
16. [Hyperaldosteronism].
Scholl UI
Internist (Berl); 2021 Mar; 62(3):245-251. PubMed ID: 33599784
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
Chen ZW; Huang KC; Lee JK; Lin LC; Chen CW; Chang YY; Liao CW; Wu VC; Hung CS; Lin YH;
J Hypertens; 2018 Feb; 36(2):353-360. PubMed ID: 28902663
[TBL] [Abstract][Full Text] [Related]
18. [Primary aldosteronism].
Fardella CE; Mosso LM; Carvajal CA
Rev Med Chil; 2008 Jul; 136(7):905-14. PubMed ID: 18949169
[TBL] [Abstract][Full Text] [Related]
19. Primary aldosteronism in hypertensive patients: clinical implications and target therapy.
Papanastasiou L; Markou A; Pappa T; Gouli A; Tsounas P; Fountoulakis S; Kounadi T; Tsiama V; Dasou A; Gryparis A; Samara C; Zografos G; Kaltsas G; Chrousos G; Piaditis G
Eur J Clin Invest; 2014 Aug; 44(8):697-706. PubMed ID: 24909545
[TBL] [Abstract][Full Text] [Related]
20. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
